Skip to main content
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 3/2012

01.03.2012 | Reports of Original Investigations

The viscous behaviour of HES 130/0.4 (Voluven®) and HES 260/0.45 (Pentaspan®)

verfasst von: Andrew M. Walker, MGIS, Kogan Lee, BSc, Gary M. Dobson, MD, Clifton R. Johnston, PhD

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Several fluids are available for volume therapy to address hypovolemia. We focus on two hydroxyethyl starches (HES) available for volume expansion in Canada, HES 130/0.4 (Voluven®) and HES 260/0.45 (Pentaspan®). Although information is available regarding their pharmacokinetic and risk/benefit profiles, this paper examines their viscous properties.

Methods

Dynamic viscosities of HES 130/0.4 and HES 260/0.45 were measured through capillary viscometry at 21°C and 37°C. The viscosities of the solutions were then measured through a closed flow loop at room temperature across physiologically relevant flow rates that maintained a laminar flow regime.

Results

Measured dynamic viscosity through capillary viscometry for HES 130/0.4 and HES 260/0.45 was 2.76 centipoises (cP) and 7.62 cP, respectively, at 21°C decreasing to 1.74 cP and 4.25 cP, respectively, at 37°C. Pipe flow analysis found that HES 130/0.4 (expiry 02/13) and HES 260/0.45 (expiry 10/10) displayed marginal variation in viscosity suggesting Newtonian behaviour. However, a sample of HES 130/0.4 (expiry 10/10) displayed an appreciable increase in viscosity (13%) at higher flow rates suggesting shear thickening behaviour.

Conclusion

This study represents an innovative characterization of not only the viscosity of two commonly utilized HES solutions but also their viscous behaviour across physiologically relevant flow rates. The shear thickening behaviour of a sample of HES 130/0.40 (expiry 10/10) at high flow rates was not expected, and the effect this result may have on endothelial cell function is unknown.
Fußnoten
1
B Braun Medical. Gelofusine. Iso-oncotic gelatin solution for intravenous volume substitution. B Braun Melsungen AG, Melsungen, Germany, 2002.
 
Literatur
1.
Zurück zum Zitat Verheij J, van Lingen A, Beishuizen A, et al. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med 2006; 32: 1030-8.PubMedCrossRef Verheij J, van Lingen A, Beishuizen A, et al. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med 2006; 32: 1030-8.PubMedCrossRef
2.
Zurück zum Zitat Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004; 32: S451-4.PubMedCrossRef Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004; 32: S451-4.PubMedCrossRef
3.
Zurück zum Zitat Dubniks M, Persson J, Grande PO. Plasma volume expansion of 5% albumin, 4% gelatin, 6% HES 130/0.4, and normal saline under increased microvascular permeability in the rat. Intensive Care Med 2007; 33: 293-9.PubMedCrossRef Dubniks M, Persson J, Grande PO. Plasma volume expansion of 5% albumin, 4% gelatin, 6% HES 130/0.4, and normal saline under increased microvascular permeability in the rat. Intensive Care Med 2007; 33: 293-9.PubMedCrossRef
4.
Zurück zum Zitat Haljamae H, Dahlqvist M, Walentin F. 3 Artificial colloids in clinical practice: pros and cons. Baillières Clin Anaesthesiol 1997; 11: 49-79.CrossRef Haljamae H, Dahlqvist M, Walentin F. 3 Artificial colloids in clinical practice: pros and cons. Baillières Clin Anaesthesiol 1997; 11: 49-79.CrossRef
5.
Zurück zum Zitat Traylor RJ, Pearl RG. Crystalloid versus colloid versus colloid: all colloids are not created equal. Anesth Analg 1996; 83: 209-12.PubMed Traylor RJ, Pearl RG. Crystalloid versus colloid versus colloid: all colloids are not created equal. Anesth Analg 1996; 83: 209-12.PubMed
6.
Zurück zum Zitat Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches different products – different effects. Anesthesiology 2009; 111: 187-202.PubMedCrossRef Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches different products – different effects. Anesthesiology 2009; 111: 187-202.PubMedCrossRef
7.
Zurück zum Zitat Villela NR, Salazar Vazquez BY, Intaglietta M. Microcirculatory effects of intravenous fluids in critical illness: plasma expansion beyond crystalloids and colloids. Curr Opin Anaesthesiol 2009; 22: 163-7.PubMedCrossRef Villela NR, Salazar Vazquez BY, Intaglietta M. Microcirculatory effects of intravenous fluids in critical illness: plasma expansion beyond crystalloids and colloids. Curr Opin Anaesthesiol 2009; 22: 163-7.PubMedCrossRef
8.
Zurück zum Zitat Woessner R, Grauer MT, Dieterich HJ, et al. Influence of a long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study. Pathophysiol Haemost Thromb 2003; 33: 121-6.PubMedCrossRef Woessner R, Grauer MT, Dieterich HJ, et al. Influence of a long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study. Pathophysiol Haemost Thromb 2003; 33: 121-6.PubMedCrossRef
9.
Zurück zum Zitat Jungheinrich C, Neff TA. Pharmokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005; 44: 681-99.PubMedCrossRef Jungheinrich C, Neff TA. Pharmokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005; 44: 681-99.PubMedCrossRef
10.
Zurück zum Zitat Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999; 25: 258-68.PubMedCrossRef Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999; 25: 258-68.PubMedCrossRef
11.
Zurück zum Zitat Salazar Vazquez BY, Martini J, Chavez Negrete A, Cabrales P, Tsai AG, Intaglietta M. Microvascular benefits of increasing plasma viscosity and maintaining blood viscosity: counterintuitive experimental findings. Biorheology 2009; 46: 167-79.PubMed Salazar Vazquez BY, Martini J, Chavez Negrete A, Cabrales P, Tsai AG, Intaglietta M. Microvascular benefits of increasing plasma viscosity and maintaining blood viscosity: counterintuitive experimental findings. Biorheology 2009; 46: 167-79.PubMed
12.
Zurück zum Zitat Martini J, Cabrales P, Tsai AG, Intaglietta M. Mechanotransduction and the homeostatic significance of maintaining blood viscosity in hypotension, hypertension and haemorrhage. J Intern Med 2006; 259: 364-72.PubMedCrossRef Martini J, Cabrales P, Tsai AG, Intaglietta M. Mechanotransduction and the homeostatic significance of maintaining blood viscosity in hypotension, hypertension and haemorrhage. J Intern Med 2006; 259: 364-72.PubMedCrossRef
13.
Zurück zum Zitat Topper JN, Gimbrone MA Jr. Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. Mol Med Today 1999; 5: 40-6.PubMedCrossRef Topper JN, Gimbrone MA Jr. Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. Mol Med Today 1999; 5: 40-6.PubMedCrossRef
14.
Zurück zum Zitat Shaaban AM, Duerinckx AJ. Wall shear stress and early atherosclerosis: a review. AJR Am J Roentgenol 2000; 174: 1657-66.PubMed Shaaban AM, Duerinckx AJ. Wall shear stress and early atherosclerosis: a review. AJR Am J Roentgenol 2000; 174: 1657-66.PubMed
15.
Zurück zum Zitat Cabrales P, Tsai AG, Intaglietta M. Hyperosmotic-hyperoncotic versus hyperosmotic-hyperviscous: small volume resuscitation in hemorrhagic shock. Shock 2004; 22: 431-7.PubMedCrossRef Cabrales P, Tsai AG, Intaglietta M. Hyperosmotic-hyperoncotic versus hyperosmotic-hyperviscous: small volume resuscitation in hemorrhagic shock. Shock 2004; 22: 431-7.PubMedCrossRef
16.
Zurück zum Zitat Salazar Vazquez BY, Cabrales P, Intaglietta M. The beneficial effects of increasing blood viscosity. In: Vincent JL, editor. Yearbook of Intensive Care and Emergency Medicine 2008. : Springer; 2008. p. 691-700. Salazar Vazquez BY, Cabrales P, Intaglietta M. The beneficial effects of increasing blood viscosity. In: Vincent JL, editor. Yearbook of Intensive Care and Emergency Medicine 2008. : Springer; 2008. p. 691-700.
17.
Zurück zum Zitat Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest 2005; 85: 9-23.PubMedCrossRef Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest 2005; 85: 9-23.PubMedCrossRef
18.
Zurück zum Zitat Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999; 282: 2035-42.PubMedCrossRef Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999; 282: 2035-42.PubMedCrossRef
19.
Zurück zum Zitat Reneman RS, Arts T, Hoeks AP. Wall shear stress – an important determinant of endothelial cell function and structure–in the arterial system in vivo. Discrepancies with theory. J Vasc Res 2006; 43: 251-69.PubMedCrossRef Reneman RS, Arts T, Hoeks AP. Wall shear stress – an important determinant of endothelial cell function and structure–in the arterial system in vivo. Discrepancies with theory. J Vasc Res 2006; 43: 251-69.PubMedCrossRef
20.
Zurück zum Zitat Mitchell GF, Parise H, Vita JA, et al. Local shear stress and brachial artery flow-mediated dilation. The Framingham heart study. Hypertension 2004; 44: 134-9.PubMedCrossRef Mitchell GF, Parise H, Vita JA, et al. Local shear stress and brachial artery flow-mediated dilation. The Framingham heart study. Hypertension 2004; 44: 134-9.PubMedCrossRef
21.
Zurück zum Zitat London MJ, Ho JS, Triedman JK, et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1989; 97: 785-97.PubMed London MJ, Ho JS, Triedman JK, et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1989; 97: 785-97.PubMed
22.
Zurück zum Zitat Dammers R, Stifft F, Tordoir JH, Hameleers JM, Hoeks AP, Kitslaar PJ. Shear stress depends on vascular territory: comparison between common carotid and brachial artery. J Appl Physiol 2003; 94: 485-9.PubMed Dammers R, Stifft F, Tordoir JH, Hameleers JM, Hoeks AP, Kitslaar PJ. Shear stress depends on vascular territory: comparison between common carotid and brachial artery. J Appl Physiol 2003; 94: 485-9.PubMed
23.
Zurück zum Zitat Simon AC, Levenson J, Flaud P. Pulsatile flow and oscillating wall shear stress in the brachial artery of normotensive and hypertensive subjects. Cardiovasc Res 1990; 24: 129-36.PubMedCrossRef Simon AC, Levenson J, Flaud P. Pulsatile flow and oscillating wall shear stress in the brachial artery of normotensive and hypertensive subjects. Cardiovasc Res 1990; 24: 129-36.PubMedCrossRef
24.
Zurück zum Zitat Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343: 611-7.PubMedCrossRef Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343: 611-7.PubMedCrossRef
25.
Zurück zum Zitat Gisvold SE, Brubakk AO. Measurement of instantaneous blood-flow velocity in the human aorta using pulse Doppler ultrasound. Cardiovasc Res 1982; 16: 26-33.PubMedCrossRef Gisvold SE, Brubakk AO. Measurement of instantaneous blood-flow velocity in the human aorta using pulse Doppler ultrasound. Cardiovasc Res 1982; 16: 26-33.PubMedCrossRef
26.
Zurück zum Zitat Kilner PJ, Manzara CC, Mohiaddin RH, et al. Magnetic resonance jet velocity mapping in mitral and aortic valve stenosis. Circulation 1993; 87: 1239-48.PubMed Kilner PJ, Manzara CC, Mohiaddin RH, et al. Magnetic resonance jet velocity mapping in mitral and aortic valve stenosis. Circulation 1993; 87: 1239-48.PubMed
27.
Zurück zum Zitat Degremont AC, Ismail M, Arthaud M, et al. Mechanisms of postoperative prolonged volume expansion with low molecular weight hydroxyethyl starch (HES 200/0.62, 6%). Intensive Care Med 1995; 21: 577-83.PubMedCrossRef Degremont AC, Ismail M, Arthaud M, et al. Mechanisms of postoperative prolonged volume expansion with low molecular weight hydroxyethyl starch (HES 200/0.62, 6%). Intensive Care Med 1995; 21: 577-83.PubMedCrossRef
28.
Zurück zum Zitat Monkos K. On the hydrodynamics and temperature dependence of the solution conformation of human serum albumin from viscometry approach. Biochim Biophys Acta 2004; 1700: 27-34.PubMed Monkos K. On the hydrodynamics and temperature dependence of the solution conformation of human serum albumin from viscometry approach. Biochim Biophys Acta 2004; 1700: 27-34.PubMed
29.
Zurück zum Zitat Kroemer H, Haass A, Müller K, et al. Haemodilution therapy in ischaemic stroke: plasma concentrations and plasma viscosity during long-term infusion of dextran 40 or hydroxyethyl starch 200/0.5. Eur J Clin Pharmacol 1987; 31: 705-10.PubMedCrossRef Kroemer H, Haass A, Müller K, et al. Haemodilution therapy in ischaemic stroke: plasma concentrations and plasma viscosity during long-term infusion of dextran 40 or hydroxyethyl starch 200/0.5. Eur J Clin Pharmacol 1987; 31: 705-10.PubMedCrossRef
31.
Zurück zum Zitat Cabrales P, Tsai AG, Intaglietta M. Is resuscitation from hemorrhagic shock limited by blood oxygen-carrying capacity of blood viscosity? Shock 2007; 27: 380-9.PubMedCrossRef Cabrales P, Tsai AG, Intaglietta M. Is resuscitation from hemorrhagic shock limited by blood oxygen-carrying capacity of blood viscosity? Shock 2007; 27: 380-9.PubMedCrossRef
33.
Zurück zum Zitat Stoneham MD. An evaluation of methods of increasing the flow rate of i.v. fluid administration. Br J Anaesth 1995; 75: 361-5.PubMed Stoneham MD. An evaluation of methods of increasing the flow rate of i.v. fluid administration. Br J Anaesth 1995; 75: 361-5.PubMed
34.
Zurück zum Zitat Cano-Ruiz ME, Richter RL. Changes in physicochemical properties of retort-sterilized dairy beverages during storage. J Dairy Sci 1998; 81: 2116-23.PubMedCrossRef Cano-Ruiz ME, Richter RL. Changes in physicochemical properties of retort-sterilized dairy beverages during storage. J Dairy Sci 1998; 81: 2116-23.PubMedCrossRef
35.
Zurück zum Zitat Severa L, Nedomova S, Buchar J. Influence of storing time and temperature on the viscosity of egg yolk. J Food Eng 2010; 96: 266-9.CrossRef Severa L, Nedomova S, Buchar J. Influence of storing time and temperature on the viscosity of egg yolk. J Food Eng 2010; 96: 266-9.CrossRef
Metadaten
Titel
The viscous behaviour of HES 130/0.4 (Voluven®) and HES 260/0.45 (Pentaspan®)
verfasst von
Andrew M. Walker, MGIS
Kogan Lee, BSc
Gary M. Dobson, MD
Clifton R. Johnston, PhD
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 3/2012
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-011-9648-6

Weitere Artikel der Ausgabe 3/2012

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 3/2012 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.